Merck KGaA
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRK.F | KRK.WA | 002720.KS | 4521.T | MERK.JK | 3933.HK | |
|---|---|---|---|---|---|---|
| Market cap | 65.87B | 33.00B | 70.36B | 147.31B | 1.58T | 15.37B |
| P/E (TTM) | 27.8 | 18.6 | — | 69.0 | 4.8 | 28.9 |
| Forward P/E | 16.7 | — | — | 40.4 | — | 11.3 |
| Price/book | 2.2 | 12.6 | — | 1.0 | 1.7 | 0.8 |
| Dividend yield | 1.49% | 3.61% | 0.89% | 5.03% | 8.02% | 6.47% |
| 1-year change | +37.23% | +22.89% | −20.94% | +3.14% | +12.09% | −41.08% |
| Today | +0.50% | −0.18% | −1.63% | +2.91% | +2.92% | +6.41% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All MRK.F news ›Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites
Lonza plans to more than double its U.S. footprint of contract development and manufacturing organization (CDMO) sites by agreeing to acquire five such sites in the U.S. from Merck KGaA, Darmstadt, Germany, in a deal the companies would…
More from 1 other outlet
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
MINNEAPOLIS, Sept. 23, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt…
Lonza to Acquire Merck KGaA’s US CDMO Business, Adding ADC, Viral Vector, and LNP Capacity
The deal adds five US sites and about 1,100 employees, more than doubling Lonza’s US network and filling a gap in US bioconjugation capacity the company flagged weeks earlier. “It will significantly expand our US presence, bringing us even…
Merck KGaA to divest CDMO business to Lonza
November 3, 2026 | By Mary Bailey Lonza will acquire the business for a mid-triple-digit million-euro amount. The transaction is expected to close in mid-2027, subject to customary regulatory approvals and other closing conditions. The…
More from 4 other outlets
Lonza to buy Merck KGaA’s contract manufacturing business
The Swiss contract development and manufacturing organization (CDMO) Lonza has agreed to buy the drug services business of Germany’s Merck KGaA. The purchase will give Lonza five new manufacturing sites in the US, doubling the company’s US…
More from 1 other outlet
Portfolio reshuffle: Lonza buys Merck KGaA's CDMO arm
The sale gives Lonza added US manufacturing capacity and extends its run of portfolio reshaping, while Merck KGaA sharpens its life science focus. Germany’s Merck has signed an agreement to sell its contract development and manufacturing…
Lonza agrees to buy 5 Merck KGaA facilities to accelerate US expansion
Lonza has struck a deal to buy five U.S. manufacturing plants from Merck KGaA at a valuation ranging in the low- to mid-triple-digit millions in Swiss francs. Responding to an analyst on a conference call Tuesday, Lonza CEO Wolfgang…
Merck’s Pipeline Could Be Its Next Big Growth Driver. Its Latest Earnings Offer a Clue.
Merck just posted its sixth straight earnings beat and its CEO is targeting $70 billion in mid-2030s revenue, yet the stock carries a looming patent cliff that could reshape everything. Whether the pipeline saves the story or the bears…
Lonza to Buy Five Merck Drug-Manufacturing Plants, Including Carlsbad Site
One asset is explicitly staying put. BioReliance Contract Testing Services is not included in the transaction and will remain an important part of Merck's Life Science portfolio, the company said in its statement. Until the sale closes,…
Lonza to Buy Merck KGaA's US CDMO Sites, Lifting American Footprint to Nine Plants
Lonza Group AG has agreed to acquire the contract development and manufacturing organization (CDMO) business of Germany's Merck KGaA, a deal that will take the Swiss contractor's U.S. production network from four sites to nine and add…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com43
- marketbeat.com24
- seekingalpha.com12
- defenseworld.net9
- themarketsdaily.com9
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.